RxDoctor Payments Data

Arianne Hollman, PA

Physician Assistant · Lincoln, NENPI 1659836674

Payments from drug & device makers

$1,527in general payments, 2019–2025

Across 85 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$425
  • Otsuka America Pharmaceutical, Inc.$269
  • Novo Nordisk$165
  • Bayer$122
  • Astellas Pharma US Inc$116
  • Axsome Therapeutics, Inc.$64
  • plus $366 from 13 others

What the payments were for

  • Food & beverage$1,527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,527 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$791
Medicare patients
26
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin88$76,290
TrulicityDulaglutide66$68,861
KerendiaFinerenone68$51,704
OzempicSemaglutide30$41,399
JanuviaSitagliptin Phosphate49$36,245
MounjaroTirzepatide23$26,023
RexultiBrexpiprazole15$21,673
FarxigaDapagliflozin Propanediol22$18,600
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,426
RybelsusSemaglutide12$11,689
EliquisApixaban17$10,273
SymbicortBudesonide/Formoterol Fumarate42$10,091
Tresiba Flextouch U-100Insulin Degludec18$9,452
LinzessLinaclotide15$8,510
Repatha SureclickEvolocumab12$7,441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$45$94,88589 claims
Novo NordiskOzempic, Rybelsus$165$53,08942 claims
BayerKerendia$122$51,70468 claims
MerckJanuvia$17$36,24549 claims
Otsuka America Pharmaceutical, Inc.Rexulti$269$21,67315 claims
GSKTrelegy Ellipta$11$16,42621 claims
PfizerEliquis$62$10,27317 claims
AbbVieLinzess$425$8,51015 claims
Astellas Pharma US IncMyrbetriq$116$5,34612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →